New Therapeutic Target for Prostate Cancer [News in Brief]

New research indicates a potential therapeutic target for castration-resistant prostate cancer: ROR, which is abundant in the disease, can drive androgen receptor hyperactivity. Blocking ROR with small-molecule antagonists suppresses AR and impedes tumor growth in mice bearing human prostate tumors, including a model resistant to the antiandrogen enzalutamide.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: News in Brief Source Type: research